Back
ZyVersa Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
ZVSA
ZyVersa Therapeutics
Last Price:
1.10
Seasonality Move:
-77.19%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.ZyVersa Therapeutics Price Quote
$1.10
-0.04 (-3.51%)
(Updated: November 22, 2024 at 12:50 PM ET)
ZyVersa Therapeutics Key Stats
Sell
8
ZyVersa Therapeutics (ZVSA)
is a Sell
Day range:
$1.11 - $1.18
52-week range:
$1.04 - $42.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.38%
Volume:
242.8K
Avg. volume:
2.6M
1-year change:
-95.74%
Market cap:
$2.7M
Revenue:
$0
EPS:
$-113.75
How Much Does ZyVersa Therapeutics Make?
Data Unavailable
Is ZyVersa Therapeutics Growing As A Company?
Data Unavailable
ZyVersa Therapeutics Stock Price Performance
-
Did ZyVersa Therapeutics Stock Go Up Last Month?
ZyVersa Therapeutics share price went down by -50.43% last month -
Did ZVSA's Share Price Rise Over The Last Year?
ZVSA share price fell by -95.74% over the past 1 year
What Is ZyVersa Therapeutics 52-Week High & Low?
-
What Is ZyVersa Therapeutics’s 52-Week High Share Price?
ZyVersa Therapeutics has traded as high as $42.39 over the past 52 weeks -
What Is ZyVersa Therapeutics’s 52-Week Low Share Price?
ZyVersa Therapeutics has traded as low as $1.04 over the past 52 weeks
ZyVersa Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ZyVersa Therapeutics?
-
How Much Debt Does ZyVersa Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does ZyVersa Therapeutics Have?
Cash and short term investments quarterly total is $122.9K -
What Is ZyVersa Therapeutics’s Book Value Per Share?
Book value per share is 6.54
Is ZyVersa Therapeutics Cash Flow Positive?
-
What Is ZVSA Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.1M -
What Is ZyVersa Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $7.7M -
What Is ZyVersa Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
ZyVersa Therapeutics Return On Invested Capital
Data Unavailable
ZyVersa Therapeutics Earnings Date & Stock Price
-
What Is ZyVersa Therapeutics's Stock Price Today?
A single share of ZVSA can be purchased today for 1.14 -
What Is ZyVersa Therapeutics’s Stock Symbol?
ZyVersa Therapeutics trades on the nasdaq under the ticker symbol: ZVSA -
When Is ZyVersa Therapeutics’s Next Earnings Date?
The next quarterly earnings date for ZyVersa Therapeutics is scheduled on November 22, 2024 -
When Is ZVSA's next ex-dividend date?
ZyVersa Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy ZyVersa Therapeutics Stock?
You can buy ZyVersa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ZyVersa Therapeutics Competitors
-
Who Are ZyVersa Therapeutics's Competitors?
Below is a list of companies who compete with ZyVersa Therapeutics or are related in some way:
ZyVersa Therapeutics Dividend Yield
-
What Is ZVSA Dividend Yield?
ZyVersa Therapeutics’s dividend yield currently is 0% -
What Is ZyVersa Therapeutics’s Payout Ratio?
ZyVersa Therapeutics’s payout ratio is 0% -
When Did ZyVersa Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is ZyVersa Therapeutics’s Dividend Per Share?
ZyVersa Therapeutics pays a dividend of $0.00 per share
ZyVersa Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -51.88% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 20.00 |
| Upside from Last Price: | 1654.39% |